Australian men face delayed cancer treatment without access to genetic testing

Ross Lamb, diagnosed with aggressive prostate cancer in December 2021, discovered he carried the BRCA2 mutation linked to hereditary cancer. Experts warn that many Australian men lack access to life-saving genetic testing due to an absence of a national framework, risking undiagnosed cases and delayed treatment options. Time is critical, as each year without reform costs lives.

Summary by Glance · The Age